Pancreatic cancer is a devastating condition that is most often characterized by a poor prognosis. Microarray technologies are promising screening methods for the identification of potential markers for early diagnosis and chemotherapeutic intervention. In this article, we review the current state of pancreatic cancer research as it relates to the measurement of gene transcript levels by DNA microarray analysis.
References
1.
JemalA.SiegelR.WardE.Cancer Statistics, 2006. CA Cancer J Clin56, 106–130 (2006).
2.
Van CutsemE.AertsR.HaustermansK.TopalB.Van SteenbergenW.VerslypeC.Systemic treatment of pancreatic cancer. European Journal of Gastroenterology & Hepatology16, 265–274 (2004).
3.
ShiX.LiuS.KleeffJ.FriessH.BüchlerM. W.Acquired Resistance of Pancreatic Cancer Cells towards 5-Fluorouracil and Gemcitabine Is Associated with Altered Expression of Apoptosis-Regulating Genes. Oncology62, 354–362 (2002).
4.
VenablesJ. P.Aberrant and Alternative Splicing in Cancer. Cancer Res64, 7647–754 (2004).
5.
SreekumarR.UnnikrishnanJ.FuA.Impact of high-fat diet and antioxidant supplement on mitochondrial functions and gene transcripts in rat muscle. Am J Physiol Endocrinol Metab282, E1055–E1061 (2002).
6.
SreekumarR.HalvatsiotisP.SchimkeJ. C.NairK. S.Gene Expression Profile in Skeletal Muscle of Type 2 Diabetes and the Effect of Insulin Treatment. Diabetes51, 1913–1920 (2002).
7.
OhyamaH.MahadevappaM.LuukkaaH.ToddR.WarringtonJ. A.WongD. T.Use of laser capture microdissection-generated targets for hybridization of high-density oligonucleotide arrays. Methods in Enzymology356, 323–333 (2002).
8.
Crnogorac-JurcevicT.EfthimiouE.CapelliP.Gene expression profiles of pancreatic cancer and stromal desmoplasia. Oncogene20, 7437–7446 (2001).
9.
MillenaarF.OkyereJ.MayS.van ZantenM.VoesenekL.PeetersA.How to decide? Different methods of calculating gene expression from short oligonucleotide array data will give different results. BMC Bioinformatics7, 137 (2006).
10.
GarceaG.NealC. P.PattendenC. J.StewardW. P.BerryD. P.Molecular prognostic markers in pancreatic cancer: A systematic review. Eur J Cancer41, 2213–2236 (2005).
11.
Iacobuzio-DonahueC. A.AshfaqR.MaitraA.Highly expressed genes in pancreatic ductal adenocarcinomas: A comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res63, 8614–8622 (2003).
12.
FukushimaN.KoopmannJ.SatoN.Gene expression alterations in the non-neoplastic parenchyma adjacent to infiltrating pancreatic ductal adenocarcinoma. Mod Pathol18, 779–787 (2005).
13.
AguirreA. J.BrennanC.BaileyG.High-resolution characterization of the pancreatic adenocarcinoma genome. Proc Natl Acad Sci USA101, 9067–9072 (2004).
14.
Crnogorac-JurcevicT.EfthimiouE.NielsenT.Expression profiling of microdissected pancreatic adenocarcinomas. Oncogene21, 4587–4594 (2002).
15.
NakamuraT.FurukawaY.NakagawaH.Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection. Oncogene23, 2385–2400 (2004).
16.
FriessH.DingJ.KleeffJ.Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer. Cell Mol Life Sci60, 1180–1199 (2003).
17.
LogsdonC. D.SimeoneD. M.BinkleyC.Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer.[erratum appears in Cancer Res.2003 Jun 15;63 (12):3445]. Cancer Res63, 2649–57 (2003).
18.
ErkanM.KleeffJ.EspositoI.Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis. Oncogene24, 4421–4432 (2005).
19.
SegaraD.BiankinA. V.KenchJ. G.Expression of HOXB2, a retinoic acid signaling target in pancreatic cancer and pancreatic intraepithelial neoplasia. Clin Cancer Res11, 3587–3596 (2005).
20.
OhuchidaK.MizumotoK.IshikawaN.The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target. Clin Cancer Res11, 785–793 (2005).
21.
GirouxV.MalicetC.BarthetM.p8 Is a New Target of Gemcitabine in Pancreatic Cancer Cells. Clin Cancer Res12, 235–241 (2006).
22.
KuoW. P.JenssenT.-K.ButteA. J.Ohno-MachadoL.KohaneI. S.Analysis of matched mRNA measurements from two different microarray technologies. Bioinformatics18, 405–412 (2002).
23.
GrutzmannR.BorissH.AmmerpohlO.Meta-analysis of microarray data on pancreatic cancer defines a set of commonly dysregulated genes. Oncogene24, 5079–5088 (2005).
24.
Crnogorac-JurcevicT.MissiagliaE.BlaveriE.Molecular alterations in pancreatic carcinoma: Expression profiling shows that dysregulated expression of S100 genes is highly prevalent. J Pathol201, 63–74 (2003).
